Journal rankings · indicator year 2022
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Domain ranking · 2022
Health Sciences journal rankings 2022
5,606 ranked journals · Domain
Health Sciences has 5,606 ranked journals in 2022. The median journal has an OJR of 0.67, below the world average of 1.00, unchanged on 2021; Q1 starts at OJR 1.13. The top three are CA A Cancer Journal for Clinicians, MMWR Surveillance Summaries, and New England Journal of Medicine.
Ranks and citation indicators: 2022. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2019–2021, the window the 2022 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Fields in Health Sciences (5)
Up to All journals5,606 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2021. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2019–2021, the window the 2022 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2019–2021 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2013 to 2022. | Compare |
|---|---|---|---|---|---|---|---|
1CA A Cancer Journal for CliniciansOAWiley · United States | 132.78Q1 | 551.34 257.03 up from 2021 | 81 | 100% | $4,330 | ||
2MMWR Surveillance SummariesOACenters for Disease Control and Prevention · United States | 23.43Q1 | 77.05 9.67 up from 2021 | 32 | 100% | — | ||
3New England Journal of MedicineMassachusetts Medical Society · United States | 14.28Q1 | 52.93 8.85 down from 2021 | 3,441 | 42% | — | ||
4The LancetElsevier BV · Netherlands | 13.17Q1 | 51.66 5.95 down from 2021 | 3,000 | 50% | $7,890 | ||
5Nature MedicineNature Portfolio · United States | 12.87Q1 | 58.74 2.16 down from 2021 | 951 | 56% | $12,690 | ||
6Nature Reviews Disease PrimersNature Portfolio · United Kingdom | 11.34Q1 | 69.00 12.48 up from 2021 | 154 | 32% | — | ||
7Endocrine ReviewsOxford University Press · United States | 9.21Q1 | 23.58 2.07 down from 2021 | 118 | 86% | $3,750 | ||
8Clinical Microbiology ReviewsAmerican Society for Microbiology · United States | 8.96Q1 | 30.89 9.64 down from 2021 | 111 | 100% | — | ||
9Periodontology 2000Wiley · United Kingdom | 8.04Q1 | 23.20 8.11 up from 2021 | 150 | 64% | $4,430 | ||
10The Lancet NeurologyElsevier BV · Netherlands | 7.72Q1 | 19.55 6.94 down from 2021 | 572 | 34% | $7,280 | ||
11MMWR Morbidity and Mortality Weekly ReportOACenters for Disease Control and Prevention · United States | 7.69Q1 | 35.51 1.12 down from 2021 | 913 | 100% | — | ||
12The Lancet OncologyElsevier BV · United Kingdom | 7.63Q1 | 25.73 0.87 down from 2021 | 1,085 | 32% | $7,280 | ||
13CirculationLippincott Williams & Wilkins · United States | 7.04Q1 | 21.56 1.46 down from 2021 | 1,889 | 11% | — | ||
14Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 6.99Q1 | 22.11 0.99 down from 2021 | 1,352 | 7% | — | ||
15The Lancet Respiratory MedicineElsevier BV · Netherlands | 6.73Q1 | 33.18 9.59 down from 2021 | 682 | 70% | $7,280 | ||
16Journal of Hematology & OncologyOABioMed Central · United Kingdom | 6.68Q1 | 24.82 1.06 up from 2021 | 499 | 100% | $4,990 | ||
17Cancer CellCell Press · Netherlands | 6.49Q1 | 25.66 1.09 up from 2021 | 527 | 100% | $10,400 | ||
18The Lancet Diabetes & EndocrinologyElsevier BV · Netherlands | 6.48Q1 | 20.21 0.32 up from 2021 | 470 | 46% | $7,280 | ||
19European Heart JournalOxford University Press · United Kingdom | 6.15Q1 | 17.74 1.96 down from 2021 | 1,655 | 65% | $5,922 | ||
20npj Digital MedicineOANature Portfolio · United States | 5.94Q1 | 19.74 0.07 down from 2021 | 437 | 100% | $4,090 | ||
21Progress in Retinal and Eye ResearchElsevier BV · Netherlands | 5.93Q1 | 17.26 0.39 down from 2021 | 153 | 67% | $6,710 | ||
22Molecular NeurodegenerationOABioMed Central · United Kingdom | 5.41Q1 | 15.85 4.86 down from 2021 | 190 | 100% | $3,090 | ||
23Journal of the American College of CardiologyElsevier BV · United States | 5.27Q1 | 15.06 1.17 down from 2021 | 2,040 | 100% | $7,166 | ||
24Journal of HepatologyElsevier BV · Denmark | 5.05Q1 | 16.90 0.02 down from 2021 | 1,119 | 17% | $5,500 | ||
25The Lancet Digital HealthOAElsevier BV · United Kingdom | 5.00Q1 | 19.76 0.89 up from 2021 | 321 | 100% | $6,680 | ||
26Annals of OncologyElsevier BV · Netherlands | 4.97Q1 | 17.12 1.68 down from 2021 | 932 | 100% | $5,080 | ||
27Nature Reviews Gastroenterology & HepatologyNature Portfolio · United Kingdom | 4.93Q1 | 24.49 1.21 up from 2021 | 443 | 25% | — | ||
28Nature Reviews Clinical OncologyNature Portfolio · United Kingdom | 4.80Q1 | 30.22 9.11 up from 2021 | 399 | 26% | — | ||
29GutBMJ · United Kingdom | 4.76Q1 | 16.68 1.31 down from 2021 | 1,017 | 48% | — | ||
30JAMA NeurologyAmerican Medical Association · United States | 4.69Q1 | 15.41 1.14 down from 2021 | 756 | 64% | — | ||
31The Lancet Regional Health - EuropeOAElsevier BV · United Kingdom | 4.68Q1 | 15.62 11.13 down from 2021 | 257 | 100% | $4,930 | ||
32Alcohol researchOANational Institute on Alcohol Abuse and Alcoholism · United States | 4.68Q1 | 10.37 0.48 up from 2021 | 42 | 100% | — | ||
33The Lancet Child & Adolescent HealthElsevier BV · United Kingdom | 4.67Q1 | 16.78 1.94 down from 2021 | 480 | 45% | $6,680 | ||
34Diabetes CareAmerican Diabetes Association · United States | 4.61Q1 | 14.11 0.15 down from 2021 | 1,471 | 90% | — | ||
35European UrologyElsevier BV · Switzerland | 4.47Q1 | 12.18 2.62 down from 2021 | 766 | 12% | $5,250 | ||
36The Lancet Infectious DiseasesElsevier BV · Netherlands | 4.45Q1 | 26.90 4.95 down from 2021 | 1,199 | 63% | $7,280 | ||
37Alzheimer s & DementiaWiley · United States | 4.39Q1 | 13.18 0.18 up from 2021 | 576 | 25% | $4,200 | ||
38The Lancet. Gastroenterology & hepatologyElsevier BV · United Kingdom | 4.39Q1 | 16.02 6.61 down from 2021 | 514 | 38% | $7,280 | ||
39Cancer DiscoveryAmerican Association for Cancer Research · United States | 4.37Q1 | 20.94 5.02 up from 2021 | 703 | 69% | — | ||
40World Journal of OncologyOAElmer Press Inc. · Canada | 4.37Q1 | 6.13 12.87 down from 2021 | 90 | 100% | — | ||
41Medical Image AnalysisElsevier BV · United Kingdom | 4.24Q1 | 11.96 1.58 down from 2021 | 710 | 56% | $4,170 | ||
42The Lancet Global HealthOAElsevier BV · Netherlands | 4.21Q1 | 14.25 2.73 down from 2021 | 984 | 100% | $6,680 | ||
43Journal of the National Comprehensive Cancer NetworkNational Comprehensive Cancer | 4.20Q1 | 12.80 0.64 down from 2021 | 580 | 40% | — | ||
44AutophagyTaylor & Francis · United States | 4.19Q1 | 11.47 0.16 up from 2021 | 608 | 100% | — | ||
45Current Obesity ReportsSpringer Science+Business Media · United States | 4.04Q1 | 11.39 1.66 up from 2021 | 133 | 67% | $5,790 | ||
46Journal of Aging & Social PolicyTaylor & Francis · United States | 4.02Q1 | 8.45 2.12 down from 2021 | 138 | 34% | — | ||
47JAMA CardiologyAmerican Medical Association · United States | 3.89Q1 | 12.73 2.41 down from 2021 | 952 | 55% | — | ||
48RadiologyRadiological Society of North America · United States | 3.89Q1 | 14.20 8.11 down from 2021 | 1,405 | 33% | — | ||
49Natural Product ReportsRoyal Society of Chemistry · United Kingdom | 3.87Q1 | 12.98 0.14 down from 2021 | 246 | 34% | — | ||
50Nature CancerNature Portfolio · United States | 3.80Q1 | 14.85 0.93 down from 2021 | 283 | 53% | $12,690 |
Fields of Health Sciences, compared.
Journals
Citations made in 2022. Corpus-wide, 89.5% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
1,311 additional Health Sciences journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2019–2021, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2022. Publication window: 2019–2021. How these summaries are calculated
- Ranked journals
- 5,606
- Window papers (baseline)
- 3,332,730 +22.1% from indicator year 2019
- Median OJR
- 0.67 -6.9% from indicator year 2019
- Rising journals (2025)
- 464
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2019–2021 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 2,007 | 2,150 | 2,285 | 2,374 | 2,486 | 2,626 | 2,757 | 2,922 | 3,062 | 3,193 | 3,364 | 3,591 | 3,809 | 4,129 | 4,361 | 4,544 | 4,757 | 4,979 | 5,239 | 5,390 | 5,462 | 5,563 | 5,606 | 5,618 | 5,549 | 5,406 | |
| Window papers (baseline) | 813,419 | 909,304 | 974,228 | 1,051,248 | 1,094,845 | 1,200,886 | 1,317,521 | 1,455,690 | 1,577,275 | 1,733,757 | 1,887,930 | 2,035,231 | 2,126,669 | 2,204,628 | 2,320,572 | 2,437,477 | 2,534,543 | 2,585,157 | 2,649,222 | 2,728,712 | 2,846,138 | 3,078,764 | 3,332,730 | 3,490,788 | 3,507,496 | 3,550,948 | |
| Median OJR | 0.50 | 0.53 | 0.56 | 0.59 | 0.61 | 0.63 | 0.6778 | 0.70 | 0.726 | 0.748 | 0.767 | 0.773 | 0.78 | 0.741 | 0.76 | 0.750 | 0.737 | 0.727 | 0.71 | 0.725 | 0.735 | 0.680 | 0.67 | 0.6776 | 0.681 | 0.69 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 3.3% | 4,151 journals |
| Retracted papers per 1,000 | Pooled rate: 1.372 per 1,000 | 4,101 journals |
| Output growth | Median: -6.3% | 5,009 journals |
| Open access share | Median: 100.0% | 5,406 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,090 | 2,959 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 20.2% | 5,241 journals |
| Review share | Median: 2.7% | 5,406 journals |
| Articles-only OJR | Median: 0.70 | 5,372 journals |
| Uncited share | Median: 37.7% | 5,406 journals |
| Citation concentration | Median: 46.2% | 5,398 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.